Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Edit, not 100 percent sure why the priority all th

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155574
(Total Views: 696)
Posted On: 05/16/2024 3:26:37 PM
Avatar
Posted By: Riztheinvestor
Re: hoops #143223
Edit, not 100 percent sure why the priority all the sudden, but yes it’s been mentioned several times during CCs. I believe Kelly specifically mentioned it during a CC and also said something to the effect of strong signals in this area.

I’d have to go looking for the CC and what exactly was said but it’s definitely been on managements radar, maybe we haven’t discussed much about it much here.

MGK can probably quote some stuff from the CCs. If not I’ll look later.

“Back around August-September 2023, CytoDyn in fact was originally slated to participate in a large MD Anderson ColoRectal Cancer clinical trial in combination with Keytruda. Originally, Scott Kelly was the key individual who arranged the murine study with Keytruda and made it a reality. Cyrus Arman though, was the man responsible for taking the results of that murine study and getting the CRC clinical trial all worked out. Unfortunately, CytoDyn shut down Cyrus' plans; they shut down his baby, the CRC clinical trial at MD Anderson; (reading that highlighted post now in retrospect proves interesting). In consideration of ohm20's reasoning, which I completely do agree with, I hypothesize that the murine study at MD Anderson had determined that leronlimab did all the meaningful work. This would be of no big surprise because in addition to being a direct CCR5 blockade, leronlimao also acts as an indirect blockade of PD-1. This would seem to indicate that Keytruda wouldn't have done much at all in terms of shrinking the impossible to treat MicroSatellite Stable tumors, (the tumors which vastly outnumber the treatable MicroSatellite Unstable tumors 5:7).“


(7)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565


Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program

⸻

Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us